<DOC>
	<DOCNO>NCT00913016</DOCNO>
	<brief_summary>To compare overall QoL ( Quality Life ) use Trial Outcome index ( TOI ) FACT-B questionnaire 3 year baseline .</brief_summary>
	<brief_title>Assessment Quality Life , Bone Density Safety Postmenopausal Breast Cancer Patients With Letrozole Therapy</brief_title>
	<detailed_description>1 . TOI sum score physical functional well-being breast cancer subscales . 2 . To assess incidence adverse event ( include cardiovascular , cerebrovascular , endocrine , musculoskeletal ) Korean postmenopausal breast cancer patient early adjuvant setting . 3 . To assess effect letrozole ( Femara ) BMD early adjuvant setting . 4 . To assess effect letrozole ( Femara ) total cholesterol early adjuvant setting .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>1 . Patients undergone surgery breast cancer prove histologically breast cancer postmenopausal woman older 45 year . Postmenopausal state define follow condition , least one , b , c. 1. serum FSH ≥ 30 mIU/mL 2. amenorrhea ≥ 1 year 3. oophorectomy 2. patient estrogen receptor ( + ) and/or progesterone receptor ( + ) 3. WHO ( ECOG ) performance status 02 4 . Adequate haematological function , renal function , hepatologic function . 5 . No evidence metastasis . 1. patient hormone receptor negative . 2 . Patients malignancy ( breast cancer ) within last 5 year , except adequately treat situ carcinoma cervix basal cell / squamous cell carcinoma skin . 3 . Other hormone therapy give within previous 4 week . 4 . Patients aromatase inhibitor chemotherapy 5 . Uncontrolled infection , medically uncontrollable heart disease 6 . Other serious medical illness prior malignancy 7 . Patients BMD Tscore ≤2.5 8 . Patients treat bisphosphonate 9 . Patients postmenopausal state induce chemotherapy 10 . Estimated life expectancy &lt; 12 month</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>hormonal therapy ( letrozole )</keyword>
	<keyword>postmenopausal breast cancer</keyword>
	<keyword>quality life</keyword>
</DOC>